GSK's 2024 vaccine sales slide on lower demand Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 5 February, 2025

The early-stage R&D landscape is evolving faster than ever. But which approaches are delivering real results? Find out — join us for Drug Discovery Day.

Spotlight In Focus Drugmakers seize on biomarkers to test the FDA's rare disease shift

news Amgen announces hold on Phase 1 obesity candidate, pipeline cuts Novo Nordisk sees growth slowing this year, plans CagriSema filing for 2026 GSK defiant against vaccine challenges, will prioritize other growth areas

Meet the VCs powering biotech’s future — what does it take to land serious funding in today’s market? Find out — sign up today.

ENDPOINTS PHARMA Pfizer says it has at least $10B available for deals in 2025, with a focus on pipeline •  Updated: Pfizer sticks to 2025 projections as Covid sales stabilize, R&D revamp continues Merck CEO says he’s confident in growth despite Gardasil ‘headwind’ •  Updated: Merck temporarily pauses Gardasil shipments to China following sales slowdown We’re about to find out which RFK Jr. will show up at HHS •  Updated: RFK Jr. advances out of Senate committee with Cassidy’s support J&J asks court for quick decision in 340B rebate model fight Bavarian Nordic’s stock sinks after 2024 revenues underwhelm Illumina added to China's blacklist following Biosecure Act, tariffs

in case you missed it 1. New study will try to stop Alzheimer’s decades before it begins, using experimental Eli Lilly drug 2. Flagship spinout Omega is days away from bankruptcy, it says in filing 3. Regeneron will start delivering quarterly dividends 37 years into its existence 4. After relaunch, Roche gets FDA approval for ocular implant in diabetic macular edema 5. Astellas shakes up management despite impressive nine-month earnings 6. FDA approves Supernus’ Parkinson’s drug-device after two rejections 7. America Can’t Just Unpause USAID 8. South Korea Plans $23 Billion Fund to Support Battery and Biotech